Shareholder Update: Q1 2017

Shareholders are invited to attend a presentation by Hexima CEO Dr Nicole van der Weerden. Upcoming Event: Tuesday 25th July at 11.30am at Lvl 38, 88 Phillip Street Sydney (offices of Bell Potter). Past Event: Monday 26th June 11am at Lvl 21, 333 Collins Street...

Hexima Shareholder Update and Share Trading

Dear Shareholder View the latest shareholder update from Hexima Limited Hexima is pleased to advise that it has completed a pivotal GLP repeat-dose dermal irritation study in minipigs for HPX124 which should provide sufficient pre-clinical animal toxicology data to...